News Digest / Ticker: HRMY

Ticker: HRMY

09:11am, Tuesday, Aug 05, 2025
Company Overview: Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) focuses on developing treatments for rare neurological diseases. The company has seen growth in its portfolio, particularly with its lead product, WAKIX, which is used in the treatment of narcolepsy. Recent Developments: - In Oct...